Loading clinical trials...

Vedic Medical Astrology in Essential Hypertension | Clinical Trials | Clareo Health

COMPLETEDNA

Vedic Medical Astrology in Essential Hypertension

Vedic Medical Astrology in Essential Hypertension: A Double-blind, Placebo-controlled Study

NCT03803306•NMP Medical Research Institute

Summary

Previous studies have explored the correlation and impact of astrological events in relation of diseases, health concerns and relationship between birth chart and disease risk. Cardiovascular conditions, sleep and fertility were found significantly associated with moon phase. However, to best of our knowledge no study has documented the impact of astrological intervention in disease management. This is a randomised, multi-center, double blind placebo controlled clinical trial with two parallel arms. This trial aims to evaluate the effectiveness of Vedic medical astrological intervention for patients with mild to moderate hypertension,with respect to decreasing their blood pressure and improving their quality of life.

Eligibility

Age

35 - 60 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients age between 35 and 60 years old, male and female;
•Patients who meet the diagnostic criteria of essential hypertension (
•Patients taking antihypertensive drugs under the supervision of physicians.
•Patients having understanding of our study and willing to comply with astrological protocol.
•Informed consent

Exclusion Criteria

•Patients who have been diagnosed as secondary hypertension or malignant hypertension
•Patients with comorbid conditions
•Patients with a chronic disease associated or psychiatric conditions which might not suitable for the study
•Patients who had been treated with any other alternative or complementary medicine during the previous three months

Locations (1)

NMP Medical Reserach Institute

Jaipur, Rajasthan, India

Key Dates

Start Date

July 12, 2018

Primary Completion Date

December 15, 2018

Completion Date

January 6, 2019

Last Updated

January 14, 2019

Enrollment

ACTUAL participants

Conditions

Essential Hypertension

Interventions

Vedic Medical Astrology

COMBINATION_PRODUCT

Placebo vedic medical astrology (PMA)

OTHER

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

NCT06823947

Healthy Volunteers Essential Hypertension

View study

ACTIVE_NOT_RECRUITING

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

NCT06604897

Essential Hypertension

View study

COMPLETEDPHASE3

PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 14, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Vedic Medical Astrology in Essential Hypertension

Inclusion Criteria

Exclusion Criteria

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA.

Mat Pilates With Paced Breathing Versus Diaphragmatic Breathing in Stage II Hypertension

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions